| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/15/2004 | US20040009550 Export and modification of (poly)peptides in the lantibiotic way |
| 01/15/2004 | US20040009548 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009547 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009546 Compositions and methods for inhibiting microbial adhesion |
| 01/15/2004 | US20040009531 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 01/15/2004 | US20040009505 A pair of genetic engineered primers for the mutagenic amplification, therapeutic treatment |
| 01/15/2004 | US20040009497 Methods and reagents for dendritic localization of polynucleotides |
| 01/15/2004 | US20040009491 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to plasma membrane associated polynucleotides, antigens, and antibodies |
| 01/15/2004 | US20040009488 Nucleic acids, proteins, and antibodies |
| 01/15/2004 | US20040009469 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/15/2004 | US20040009217 Therapeutic liposome composition and method |
| 01/15/2004 | US20040009187 Rotavirus subunit vaccine |
| 01/15/2004 | US20040009186 Immunogenic peptides |
| 01/15/2004 | US20040009164 PSP94 diagnostic reagents and assays |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009158 Administering endothelial progenitor cells comprising gene codes for proteins; prophylaxis of congenital protein defects or genetic disorders |
| 01/15/2004 | US20040009157 Methods of inducing or enhancing cartilage repair |
| 01/15/2004 | US20040009123 Methylenediphosphonate derivatives containing one or two hydroxy groups, useful for treating parasitosis and autoimmune maldy in primate |
| 01/15/2004 | DE20311944U1 Farbeffekt-Schichten und -Beschichtungen auf Basis photonischer Kristalle Color effect layers and coatings based on photonic crystals |
| 01/15/2004 | DE20311943U1 Poröse Materialien für die Blockung von UV-Strahlung Porous materials for the blocking of UV radiation |
| 01/15/2004 | DE20311942U1 Poröse Materialien für die Blockung von IR-Strahlung Porous materials for the blocking of IR radiation |
| 01/15/2004 | DE20311940U1 Poroese Materialien zur Immobilisierung von Bakterien Porous materials for the immobilization of bacteria |
| 01/15/2004 | DE20311939U1 Poröse Materialien als Katalysatorträger in chemischen und verfahrenstechnischen Anwendungen Porous materials as catalyst supports in chemical and process engineering applications |
| 01/15/2004 | DE20311937U1 Poröse Materialien für die Reinigung und Aufbereitung von Wasser Porous materials for the purification and treatment of water |
| 01/15/2004 | DE10227611A1 Verfahren und Vorrichtung zur Vermehrung und Differenzierung von Zellen in Anwesenheit von Wachstumsfaktoren und einer biologischen Matrix oder Trägerstruktur Method and apparatus for proliferation and differentiation of cells in the presence of growth factors and a biological matrix or supporting structure |
| 01/15/2004 | CA2492074A1 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | CA2491992A1 Animal protein free media for cultivation of cells |
| 01/15/2004 | CA2491890A1 A method of studying living cells |
| 01/15/2004 | CA2491690A1 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | CA2491687A1 A robust, inducible cardiac preferred expression system for transgenesis |
| 01/15/2004 | CA2491513A1 Compositions and methods for ligament growth and repair |
| 01/15/2004 | CA2491508A1 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | CA2491321A1 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 01/15/2004 | CA2491286A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | CA2491017A1 Antibodies to non-shed muc1 and muc16, and uses thereof |
| 01/15/2004 | CA2490473A1 Culture dish and bioreactor system |
| 01/15/2004 | CA2489919A1 Liposomal vaccine |
| 01/15/2004 | CA2488725A1 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 01/14/2004 | EP1380651A2 Recombinant fowlpox virus with intact FPV-tk-gene |
| 01/14/2004 | EP1380650A1 Conditionally replicating viral vectors and their use |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1380304A2 Process for the improvement of spermatozoa fertilization activity |
| 01/14/2004 | EP1379869A1 Method for therapeutically treating a clinically recognized form of cardiopathology in a living mammal |
| 01/14/2004 | EP1379701A2 Elimination of endogenous porcine retrovirus |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379682A1 Cell isolation method and uses thereof |
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379671A2 Methods to culture circovirus |
| 01/14/2004 | EP1379670A1 Activated dual specificity lymphocytes and their methods of use |
| 01/14/2004 | EP1379668A2 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells |
| 01/14/2004 | EP1379662A2 Sulfatases and methods of use thereof |
| 01/14/2004 | EP1379660A2 Self-replicating rna molecule from hepatitis c virus |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379651A2 Human genes and gene expression products isolated from human prostate |
| 01/14/2004 | EP1379649A2 Calcium binding proteins |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379646A2 Engineered chimera of protein fragments and methods of use thereof |
| 01/14/2004 | EP1379643A2 Methods for identifying and purifying smooth muscle progenitor cells |
| 01/14/2004 | EP1379642A2 Arrayed transfection method and uses related thereto |
| 01/14/2004 | EP1379639A2 Glucuronyl c5-epimerase, dna encoding the same and uses thereof |
| 01/14/2004 | EP1379638A2 Implantation serine proteinases |
| 01/14/2004 | EP1379637A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 01/14/2004 | EP1379628A2 Kinases and phosphatases sequences, and use thereof |
| 01/14/2004 | EP1379627A1 Method for differentiating mesenchymal stem cells into neural cells |
| 01/14/2004 | EP1379626A2 A method for differentiating stem cells into insulin-producing cells |
| 01/14/2004 | EP1379625A1 Cd4+cd25+ regulatory t cells from human blood |
| 01/14/2004 | EP1379624A2 Transfection of human embryonic stem cells |
| 01/14/2004 | EP1379550A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/14/2004 | EP1379539A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 01/14/2004 | EP1379535A2 Expression vectors able to elicit improved immune response and methods of using same |
| 01/14/2004 | EP1379281A2 A helper dependent adenoviral vector system and methods for using the same |
| 01/14/2004 | EP1379278A2 Method of inducing proliferation of retinal stem cells |
| 01/14/2004 | EP1379277A2 Polyclonal populations of bispecific molecules and methods of production and uses thereof |
| 01/14/2004 | EP1379275A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/14/2004 | EP1379272A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/14/2004 | EP1379268A1 Chondrogenic potential of human bone marrow-derived cd105?+ cells by bmp |
| 01/14/2004 | EP1379266A2 Modified annexin proteins and methods for preventing thrombosis |
| 01/14/2004 | EP1379265A2 Short bioactive peptides and methods for their use |
| 01/14/2004 | EP1379140A2 Production of pancreatic islet cells and delivery of insulin |
| 01/14/2004 | EP1379139A2 The use of ecm degrading enzymes for the improvement of cell transplantation |
| 01/14/2004 | EP1379133A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 01/14/2004 | EP1379125A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof |
| 01/14/2004 | EP0939644B1 Enhanced stimulation of erythropoiesis |
| 01/14/2004 | EP0832229B1 Cd40l mutein |
| 01/14/2004 | EP0690991B2 Novel anticoagulant cofactor activity |
| 01/14/2004 | CN1468317A Use of multiple recombination sites with unique specificity in recombinational cloning |
| 01/14/2004 | CN1468313A Novel constructs and their use in metabolic pathway engineering |
| 01/14/2004 | CN1468311A Isomaltulose synthase |
| 01/14/2004 | CN1468310A Method for constructing cell strain of expression mutation type human tissue plasmin activator and preparation method of expressing protein |
| 01/14/2004 | CN1468309A Anti-il-12 antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468308A Anti-tnf antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468307A Anti-dual integrin antibodies, compositions, methods and uses |
| 01/14/2004 | CN1468306A Schizophrenia related gene and protein |
| 01/14/2004 | CN1468304A Method of producing functional protein domains |
| 01/14/2004 | CN1468257A Trichosanthin mutant |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1467292A Highly effective expressing method of interleukin-12 |